Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
0.76 USD | +21.68% | +19.48% | -45.71% |
Kurzporträt
Mitarbeiterzahl: 233
Umsatz nach Geschäftsbereich
USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
Microbiome Therapeutics
100,0
%
| 7 | 100,0 % | 126 | 100,0 % | +1’672.24% |
Umsatz je Region
USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 7 | 100,0 % | 126 | 100,0 % | +1’672.24% |
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Eric Shaff
CEO | Chief Executive Officer | 48 | 01.11.14 |
David Ege
CTO | Chief Tech/Sci/R&D Officer | 50 | 22.10.20 |
Chief Tech/Sci/R&D Officer | - | 01.05.15 | |
Kelly M. Brady
CTO | Chief Tech/Sci/R&D Officer | - | 01.06.18 |
Marcus Chapman
COO | Chief Operating Officer | 53 | 01.03.15 |
Lisa von Moltke
CTO | Chief Tech/Sci/R&D Officer | 65 | 01.03.20 |
Barbara McGovern
CTO | Chief Tech/Sci/R&D Officer | - | 01.04.15 |
Matthew Henn
CTO | Chief Tech/Sci/R&D Officer | 49 | 01.06.12 |
Carlo Tanzi
IRC | Investor Relations Contact | - | 01.10.15 |
Teresa Young
PRN | Corporate Officer/Principal | 57 | 29.06.20 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Dennis Ausiello
BRD | Director/Board Member | 78 | 01.04.15 |
Director/Board Member | 68 | 04.01.23 | |
Richard Kender
BRD | Director/Board Member | 68 | 06.10.14 |
Kurt Graves
BRD | Director/Board Member | 56 | 01.11.15 |
Paul Biondi
BRD | Director/Board Member | 54 | 20.03.20 |
Eric Shaff
CEO | Chief Executive Officer | 48 | 01.11.14 |
Willard Dere
BRD | Director/Board Member | 70 | 11.07.17 |
Stephen Berenson
CHM | Chairman | 63 | 05.08.19 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 151 009 462 | 142 384 021 ( 94,29 %) | 0 | 94,29 % |
Unternehmenskontakt
Seres Therapeutics, Inc.
200 Sidney Street 4th floor
02139, Cambridge
+617 945 9626
http://www.serestherapeutics.comSektor
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
-45.71% | 94.32 Mio. | |
-0.49% | 103 Mrd. | |
+3.31% | 96.73 Mrd. | |
+1.66% | 21.31 Mrd. | |
-16.16% | 21.21 Mrd. | |
-6.82% | 18.79 Mrd. | |
-41.41% | 16.37 Mrd. | |
-22.87% | 13.68 Mrd. | |
+6.32% | 13.44 Mrd. | |
+21.46% | 10.98 Mrd. |
- Börse
- Aktien
- A14VXX Aktie
- Unternehmen Seres Therapeutics, Inc.